Onco+
Oncology Forecasting Software

Onco+, Oncology forecasting software, helps you:

Make the impossible possible, with complex algorithms built in.
Produce patient flow models to support changing treatment paradigms and the progression of patients.
Confidently forecast your Oncology product.
Reduce third party involvement and associated costs.

What is Onco+?

Onco+ is a game changing Excel add-in, specifically created for Oncology forecasting. The most accurate and precise way to forecast any Oncology product. Onco+ includes all variables related to your Oncology forecast model. The patient flow methodology underpins Onco+. Track and follow patients on treatment throughout your forecast - making this technically difficult methodology accessible to all.

Onco+ Intuitive

User-friendly design is structured in a step-by-step approach through stages/lines/regimens of forecasting

Details

Onco+ Agile

Onco+ is suited to any cancer type and allows you to make instant changes which reflect the market

Details

Onco+ Engaging

Clear, engaging, easy to interpret data with a consistent look and feel that can be easily shared and reviewed

Details

Onco+ Innovative

Risk analysis, consolidation and a Peak Share Predictor

Details

Who?

Onco+ is designed anyone involved in forecasting in New Product Planning for Oncology Forecasting whether it's in Marketing, Sales, Business Insight, Market Research or Analytics

The J+D team is very experienced and bring a lot of knowledge to their projects.They are very insightful about what sort of things to include in models. Market Analytics Manager, ViiV

J+D's Onco+ tool is a fantastic forecast platform. It is very easy and flexible to use as it is designed as a component of an Excel worksheet. It allows the users to create highly customized forecast model based on the detailed and defined patient flow in all disease areas. The tool has also analytical components including SimScore that will help to have reasonable share assessment like mini-conjoint study, and Monte Carlo Simulation for sensitive and scenario analysis. Great forecasting tool to recommend! Frank Wang, Global Business Analysis Disease Lead, Malignant Haematology